Success examples
Combining BET inhibition with SMAC mimetics restricts tumor growth and triggers immune surveillance in preclinical cancer models

Slavic Obradovic K., Ebner F., Artemov A. V., Miotto M., Traexler P-E., Jacob R., Thanh H. P. T., Ruzicka R., Wernitznig A., Baumann I., Gerlach D., Impagnatiello M-A., Siena S., Murphy M., House R., Reiser U., Santoro V., Popow J., Carotta S., Baum A., Lipp J., Bardelli A., Tontsch-Grunt U., Russo M., Aichinger M.

Cell Rep Med. 2025, 6(9):102313.